| 摘要 |
Methods are provided for increasing stem cells, hematopoietic progenitor/ste m cells, mesenchymal progenitor/stem cells, mesodermal progenitor/stem cells, muscle progenitor/stem cells, or neural progenitor/stem cells in vivo in a mammalian subject. Methods are also provided for treating an immune related disease, a mesenchymal/mesoderm degenerative disease, or a neurodegenerative disease by administering one or more Wnt/.beta.-catenin signal-, Notch signa l- , or Hedgehog signal- promoting agents to a mammalian subject in need thereo f. |
